EvokAI Creative Labs Inc. (TSXV:OKAI)

Canada flag Canada · Delayed Price · Currency is CAD
0.115
0.00 (0.00%)
Apr 27, 2026, 4:00 PM EST
-88.50%
Market Cap 874.63K
Revenue (ttm) n/a
Net Income (ttm) -18.41M
Shares Out 7.61M
EPS (ttm) -2.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 3,718
Open 0.115
Previous Close 0.115
Day's Range 0.115 - 0.115
52-Week Range 0.115 - 1.350
Beta -1.32
RSI 25.73
Earnings Date Apr 29, 2026

About EvokAI Creative Labs

EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company’s artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and pr... [Read more]

Sector Healthcare
CEO Alejandro Antalich
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol OKAI
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

EvokAI Creative Labs Sets Date for Share Consolidation

VANCOUVER, BC / ACCESS Newswire / February 3, 2025 / EvokAI Creative Labs Inc. (TSXV:OKAI)(OTCQB:OKAIF) ("EvokAI" or the "Company"), a leading MedTech AI-powered company dedicated to the development o...

1 year ago - Accesswire

EvokAI Creative Labs Receives CE Mark Approval for Its MDM Flex Sensor to Transform the Management of Parkinson's Disease

VANCOUVER, BC / ACCESSWORE / October 30, 2023 / EvokAI Creative Labs Inc. (TSXV:OKAI)(OTCQB:OKAIF) ("EvokAI" or the "Company"), a leading MedTech AI-powered company dedicated to the development of tra...

2 years ago - Accesswire

EvokAI Creative Labs Files Final Base Shelf Prospectus

VANCOUVER, BC / ACCESSWIRE / October 25, 2023 / EvokAI Creative Labs Inc. (TSXV:OKAI) ("EvokAI" or the "Company"), a leading MedTech AI-powered company dedicated to the development of transformational...

2 years ago - Accesswire

EvokAI Creative Labs Initiates CE Mark Certification for Innovative Parkinson's Disease Technology

VANCOUVER, BC / ACCESSWIRE / September 27, 2023 / EvokAI Creative Labs Inc. (TSXV:OKAI)(OTCQB:OKAIF) ("EvokAI" or the "Company"), a leading MedTech AI-powered company dedicated to the development of t...

2 years ago - Accesswire

EvokAI Creative Labs Announces Trading on the OTCQB(R) and DTC Eligibility as Part of Its Market Expansion

VANCOUVER, BC / ACCESSWIRE / July 21, 2023 / EvokAI Creative Labs Inc. (TSXV:OKAI)(OTCQB:OKAIF) ("EvokAI" or the "Company"), a leading MedTech AI-powered company dedicated to the development of transf...

3 years ago - Accesswire